- Failure of adjuvant treatment for malignant melanoma - what next?2021 | Publication without faculty affiliation
- Immunotherapy in the adjuvant treatment of patients with malignant melanoma2021 | Faculty of Medicine in Hradec Králové
- Position of adjuvant therapy in the therapy of melanoma2018 | First Faculty of Medicine
- Current status of immunotherapy in the adjuvant treatment of invasive urothelial carcinoma2023 | Faculty of Medicine in Hradec Králové
- Adjuvant durvalumab after successful concomitant chemoradiotherapy of non-small cell lung cancer treatment2021 | Faculty of Medicine in Pilsen
- Ground-breaking ADAURA trial - osimertinib as adjuvant therapy of EGFR-mutated NSCLC2022 | First Faculty of Medicine
- Non-specific immunotherapy inhibits angiogenesis - results of the monitoring of serum levels of vascular endothelial growth factor and matrix metalloproteinase 8 in patients with malignant melanoma receiving adjuvant high-dose interferon therapy2017 | First Faculty of Medicine, Central Library of Charles University
- Adjuvant Treatment of Melanoma. Review of contemporary Therapeutic Approaches2002 | Publication without faculty affiliation
- Aromatase inhibitors and their place in the adjuvant treatment of breast cancer2008 | First Faculty of Medicine
- Adjuvant treatment for breast cancer after St. Gallen 20072008 | First Faculty of Medicine
- Adjuvant therapy for melanoma in real world2023 | Faculty of Medicine in Hradec Králové
- Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy2008 | First Faculty of Medicine
- The role of C-ERB-B2 expres test for adjuvant therapy of breast cancer.1999 | Faculty of Physical Education and Sport
- Nová éra v adjuvantní léčbě pokročilého melanomu2019 | First Faculty of Medicine
- Méně je více - poselství SABCS 20152016 | First Faculty of Medicine
- Adjuvant Therapy of the Renal Carcinoma2002 | First Faculty of Medicine
- Novinky v adjuvantní léčbě melanomuPublication without faculty affiliation
- The potential of some oral anti-diabetic drugs for use as andjuvant therapy in type 1 diabetic patients2011 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial2006 | First Faculty of Medicine
- Neoadjuvant and adjuvant therapy in the treatment of colorectal carcinoma2012 | First Faculty of Medicine
- Adjuvantní léčba HER pozitivního karcinomu prsu2020 | First Faculty of Medicine
- CDK4/6 inhibitors in adjuvant therapy of breast cancer2023 | First Faculty of Medicine
- Neratinib in the adjuvant treatment of breast cancer - a case report2023 | Third Faculty of Medicine
- Personalization of neo/adjuvant treatment of HER2-positive breast cancer is the key to achieve the best results2022 | First Faculty of Medicine
- Commentary: Adjuvant navelbine International Trialist Association (ANITA)2008 | First Faculty of Medicine
- Commentary: Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial2006 | First Faculty of Medicine
- Adjuvant therapy of breast cancer. CMF orantracycline combination - result of multicentric studyPublication without faculty affiliation
- Cranberries and probiotics - prevention and adjuvant treatment of recurrent urinary tract infections2011 | Publication without faculty affiliation
- Cranberry and probiotics - prevention and adjuvant therapy of recurrent urinary tract infections2012 | Publication without faculty affiliation
- Mifamurtide - a new approach to adjuvant therapy of osteosarcomas2013 | Second Faculty of Medicine